According to OncoCyte 's latest financial reports the company's current EPS (TTM) is -9,03 โฌ. In 2022 the company made an earnings per share (EPS) of -11,68 โฌ an increase over its 2021 EPS that were of -12,49 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -9,70 โฌ | -16.94% |
2022 | -11,68 โฌ | -6.48% |
2021 | -12,49 โฌ | 54.35% |
2020 | -8,09 โฌ | 6.98% |
2019 | -7,57 โฌ | 2.38% |
2018 | -7,39 โฌ | -34.38% |
2017 | -11,26 โฌ | 48.84% |
2016 | -7,57 โฌ | -35.18% |
2015 | -11,67 โฌ |